The American Society for Pharmacology and Experimental Therapeutics offers symposia on cannabinoids (a chemical compound in cannabis or marijuana), endocannabinoids (a marijuana-like substance) and pain associated with inflammation, stress, psychiatric disorders, neurodegenerative disorders, and other disorders; the future of pharmacogenomics and its clinical applications; nanotechnology in disease therapeutics; osteoporosis and bone research (a symposium subtitled "no time to be bad to the bone"); toxicology of nanomaterials (including effects on the skin and lungs); the ways in which nicotine modulates adolescent brain plasticity, interacts with other drugs during sensitive developmental periods, and, when used along with alcohol by a woman during pregnancy, alters drug responsiveness in offspring; an examination of why children, adolescents and adults respond differently to antidepressants; studies of how perinatal stress, such as maternal separation, affects drug response and propensity to abuse drugs as an adult; and cardiovascular gene therapy.
The American Physiological Society program includes 16 societal or distinguished lectures and a Physiology Infocus session that focuses on novel technologies in physiology and medicine, such as advances in forensic medicine, new approaches in imaging, and the use of experimental evolution (selecting for particular physiological attributes in large laboratory populations) as a tool of physiological analysis. Other workshops include human subject research ethics and the challenge of presenting basic research in an anti-science, anti-evolution and anti-education era. Among topics for symposia or individual research presentations are: cancer and hypoxia (starving tumors of oxygen) ; pharmacogenomics of estrogen and cardiovascular disease; roles of intestinal epithelia and bacteria in inflammatory disease; and the potential benefits of
Contact: Sylvia Wrobel
Federation of American Societies for Experimental Biology